Metal and magnetic nanostructures for cancer detection, imaging, and therapy

Journal of Biomedical Nanotechnology

Volumn 4, Issue 4, 2008, Pages 377-399

  Rozanova, Nadejda Lvovna ^a   Zhang, Jin Zhong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer detection; Cancer therapy; Drug delivery; Imaging; Magnetic nanostructures; Metal nanostructures; Photodynamic therapy; Photothermal ablation therapy

Indexed keywords

ABLATION; APPLICATIONS; CUSTOMER SATISFACTION; DRUG DELIVERY; DRUG THERAPY; MAGNETIC MATERIALS; MAGNETIC PROPERTIES; MAGNETISM; METALS; NANOSTRUCTURED MATERIALS; NANOSTRUCTURES; OPTICAL MATERIALS; PLASMONS;

CANCER DETECTION; CANCER THERAPY; IMAGING; MAGNETIC NANOSTRUCTURES; METAL NANOSTRUCTURES; PHOTOTHERMAL ABLATION THERAPY;

PHOTODYNAMIC THERAPY;

FERUMOXYTOL; FLUOROURACIL; GADOLINIUM; GEMCITABINE; LIPOSOME; MACROGOL; MERCAPTOPURINE; METAL NANOPARTICLE; METHOTREXATE; NANOMATERIAL; NANOSHELL; NANOSPHERE; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ALUMINUM; POLYCAPROLACTONE; PORPHYRIN DERIVATIVE; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TECHNETIUM 99M; TRASTUZUMAB; TRIPTORELIN;

ANTIANGIOGENIC THERAPY; BRAIN TUMOR; CANCER DIAGNOSIS; CANCER INHIBITION; CANCER THERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DRUG DELIVERY SYSTEM; DRUG TARGETING; EHRLICH ASCITES TUMOR; GLIOMA; HUMAN; HYPERTHERMIC THERAPY; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MAGNETIC FIELD; MELANOMA; MULTIPLE MYELOMA; NANOPHARMACEUTICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PANCREAS ADENOCARCINOMA; PHOTOCHEMICAL INTERNALIZATION; PHOTODYNAMIC THERAPY; PROSTATE CANCER; RAMAN SPECTROMETRY; REVIEW; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TUMOR REGRESSION;

EID: 58149288231     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2008.003     Document Type: Review

References (100)

1. M. Shinkai, M. Suzuki, S. Iijima, and T. Kobayashi, Antibody-conjugated magnetoliposomes for targeting cancer cells and their application in hyperthermia. Biotechnol. Appl. Biochem. 21, 125 (1995).
2. J. A. Frank, B. R. Miller, A. S. Arbab, H. A. Zywicke, E. K. Jordan, B. K. Lewis, L. H. Bryant, and J. W. M. Bulte, Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228, 480 (2003).
3. G. Han, P. Ghosh, and V. M. Rotello, Functionalized gold nanoparticles for drug delivery. Nanomedical 2, 113 (2007).
4. Y. Nishioka and H. Yoshino, Lymphatic targeting with nanoparticulate system. Adv. Drug Deliv. Rev. 47, 55 (2001).
5. O. C. Farokhzad, J. Cheng, and B. A. Teply, Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. USA 103, 6315 (2006).
6. M. D. Wang, D. M. Shin, J. W. Simons, and S. Nie, Nanotechnology for targeted cancer therapy. Expert. Rev. Anticancer Ther. 7, 833 (2007).
7. A. S. Lubbe, C. Alexiou, and C. Bergemann, Clinical applications of magnetic drug targeting. J. Surg. Res. 95, 200 (2001).
8. C. Loo, A. Lowery, and N. Halas, Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 5, 709 (2005).
9. J. F. Hainfeld, D. N. Slatkin, T. M. Focella, and H. M. Smilowitz, Gold nanoparticles: A new X-ray contrast agent. Br. J. Radiol. 79, 248 (2006).
10. P. Alivisatos, The use of nanocrystals in biological detection. Nat. Biotechnol. 22, 47 (2004).
11. C.-C. You, O. R. Miranda, B. Gider, P. S. Ghosh, I.-B. Kim, B. Erdogan, S. A. Krovi, U. H. F. Bunz, and V. M. Rotello, Detection and identification of proteins using nanoparticle? Fluorescent polymer 'chemical nose' sensors. Nature Nanotech. 2, 318 (2007).
12. A. Jordan, P. Wust, R. Scholz, and H. Fahling, Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. Int. J. Hyperthermia 13, 587 (1997).
13. C. Alexiou, W. Arnold, R. J. Klein, F. G. Parak, P. Hulin, C. Bergemann, W. Erhardt, S. Wagenpfeil, and A. S. Lübbe, Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 60, 6641 (2000).
14. A. Ito, K. Tanaka, H. Honda, S. Abe, H. Yamaguchi, and T. Kobayashi, Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles. J. Biosci. Bioeng. 96, 364 (2003).
15. M. Johannsen, B. Thiesen, U. Gneveckow, K. Taymoorian, N. Waldoefner, and R. Scholz, Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer. Prostate 66, 97 (2006).
16. T. Minamimura, H. Sato, S. Kasaoka, T. Saito, S. Ishizawa, S. Takemori, K. Tazawa, and K. Tsukada, Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats. Int. J. Oncol. 16, 1153 (2000).
17. N. Kawai, A. Ito, Y. Nakahara, M. Futakuchi, T. Shirai, H. Honda, T. Kobayashi, and K. Kohri, Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats. Prostate 64, 373 (2005)
18. M. V. Yezhelyev, X. Gao, Y. Xing, A. Al-Hajj, S. Nie, and R. M. O'Regan, Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol. 7, 657 (2006).
19. N. Kawai, A. Ito, Y. Nakahara, H. Honda, T. Kobayashi, M. Futakuchi, T. Shirai, K. Tozawa, and K. Kohri, Complete regression of experimental prostate cancer in nude mice by repeated hyperthermia using magnetite cationic liposomes and a newly developed solenoid containing a ferrite core. Prostate 66, 718 (2006).
20. S. Hamaguchi, I. Tohnai, A. Ito, K. Mitsudo, T. Shigetomi, M. Ito, H. Honda, T. Kobayashi, and M. Ueda, Selective hyperthermia using magnetoliposomes to target cervical lymph node metastasis in a rabbit tongue tumor model. Cancer Sci. 94, 834 (2003).
21. I. H. El-Sayed, X. Huang, and M. A. El-Sayed, Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett. 239, 129 (2006).
22. L. R. Hirsch, R. J. Stafford, J. A. Bankson, S. R. Sershen, B. Rivera, and R. E. Price, Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. USA 100, 13549 (2003).
23. M. Suzuki, M. Shinkai, H. Honda, and T. Kobayashi, Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes. Melanoma Res. 13, 129 (2003).
24. A. Jordan, P. Wust, H. Fähling, W. John, A. Hinz, and R. Felix, Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia. Int. J. Hyperthermia 9, 51 (1993).
25. L. R. Hirsch, R. J. Stafford, J. A. Bankson, S. R. Sershen, B. Rivera, R. E. Price, J. D. Hazle, N. J. Halas, and J. L. West, Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. USA 100, 13549 (2003).
26. M. Everts, V. Saini, J. L. Leddon, R. J. Kok, M. Stoff-Khalili, M. A. Preuss, and C. L. Millican, Covalently linked Au nanoparticles to a viral vector: Potential for combined photothermal and gene cancer therapy. Nano Lett. 6, 587 (2006).
27. A. K. Gupta and M. Gupta, Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26, 3995 (2005).
28. J. C. Love, L. A. Estroff, J. K. Kriebel, R. G. Nuzzo, and G. M. Whitesides, Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chem. Rev. 105, 1103 (2005).
29. P. Mulvaney, Surface plasmon spectroscopy of nanosized metal particles. Langmuir 12, 788 (1996).
30. J. Yang, S. B. Park, H. G. Yoon, Y. M. Huh, and S. Haam, Preparation of poly epsilon-caprolactone nanoparticles containing magnetite for magnetic drug carrier. Int. J. Pharm. 324, 185 (2006).
31. S. Nie, Y. Xing, G. J. Kim, and J. W. Simons, Nanotechnology applications in cancer. Annu. Rev. Biomed. Eng. 9, 257 (2007).
32. M. C. Daniel and D. Astroc, Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 104, 293 (2004).
33. R. J. Esther, R. Bhattacharya, M. Ruan, M. E. Bolander, D. Mukhopadhyay, G. Sarkar, and P. Mukherjee, Gold nanoparticles do not affect the global transcriptional program of human umbilical vein endothelial cells: A DNA-microarray analysis. J. Biomed. Nanotech. 3, 328 (2005).
34. E. E. Connor, J. Mwamuka, A. Gole, C. J. Murphy, and M. D. Wyatt, Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1, 325 (2005).
35. R. Bhattacharyaa and P. Mukherjee, Biological properties of "naked" metal nanoparticles. Adv. Drug Deliv. Rev. 60, 1289 (2008).
36. S. E. Skrabalak, L. Au, X. Lu, X. Li, and Y. Xia, Gold nanocages for cancer detection and treatment. Nanomedicine 2, 657 (2007).
37. A. A. Kuznetsov, V. I. Filippov, R. N. Alyautdin, N. L. Torshina, and O. A. Kuznetsov, Application of magnetic liposomes for magnetically guided transport of muscle relaxants and anti-cancer photodynamic drugs. J. Magn. Magn. Mater. 225, 95 (2001).
38. I. T. Cinteza, T. Y. Ohulchanskyy, Y. Sahoo, E. J. Bergey, R. K. Pandey, and P. N. Prasad, Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy. Mol. Pharm. 3, 415 (2006).
39. C. Alexiou, R. Jurgons, R. J. Schmid, C. Bergemann, J. Henke, W. Erhardt, E. Huenges, and F. Parak, Magnetic drug targeting-biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J. Drug Target. 11, 139 (2003).
40. W. Wei, C. Xu, and H. Wu, Magnetic iron oxide nanoparticles mediated gene therapy for breast cancer-an in vitro study. J. Huazhong Univ. Sci. Technolog. Med. Sci. 26, 728 (2006).
41. U. J. R. Valdivia, G. M. R. Ibarra, P. R. Fernández, A. Viloria, T. Higuera, A. Laborda, A. García, J. A. G. de Jalón, M. Gutiérrez, M. S. Romero, R. Cornudella, M. Arruebo, C. Marquina, J. Arbiol, and J. Santamaría, Research study on renal targeted chemotherapy with magnetic harpoons and intravenous administration of ferro-carbon nanoparticles. Arch. Esp. Urol. 60, 5 (2007).
42. 4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model. J. Drug Target. 5, 445 (2007).
43. B. Chertok, A. E. David, Y. Huang, and V. C. Yang, Glioma selectivity of magnetically targeted nanoparticles: A role of abnormal tumor hydrodynamics. J. Control Release 8, 315 (2007).
44. B. Chertok, B. A. Moffat, A. E. David, F. Yu, C. Bergemann, B. D. Ross, and V. C. Yang, Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29, 487 (2008).
45. 4 nanoparticles in vitro. J. Mater. Sci. Mater Med. 18, 2145 (2007).
46. 4 and polylactide nanofibers for application in drug uptake and induction of cell death of leukemia cancer cells. Langmuir 24, 2151 (2008).
47. J. S. Kim, T. J. Yoon, K. N. Yu, M. S. Noh, M. Woo, B. G. Kim, K. H. Lee, B. H. Sohn, S. B. Park, J. K. Lee, and M. H. Cho, Cellular uptake of magnetic nanoparticle is mediated through energy-dependent endocytosis in A549 cells. J. Vet. Sci. 7, 321 (2006).
48. M. Uchida, M. L. Flenniken, M. Allen, D. A. Willits, B. E. Crowley, S. Brumfield, A. F. Willis, L. Jackiw, M. Jutila, M. J. Young, and T. Douglas, Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. J. Am. Chem. Soc. 27, 16626 (2006).
49. S. S. Kakar, H. Jin, B. Hung, J. W. Eaton, and K. A. Kang, LHRH receptor targeted therapy for breast cancer. Adv. Exp. Med. Biol. 614, 285 (2008).
50. M. S. Martina, J. P. Fortin, L. Fournier, C. Ménager, F. Gazeau, O. Clément, and S. Lesieur, Magnetic targeting of rhodamine-labeled superparamagnetic liposomes to solid tumors: In vivo tracking by fibered confocal fluorescence microscopy. Mol. Imaging 6, 140 (2007).
51. C. Alexiou, R. Jurgons, C. Seliger, O. Brunke, H. Iro, and S. Odenbach, Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting. Anticancer. Res. 27, 2019 (2007).
52. R. E. Serda, N. L. Adolphi, M. Bisoffi, and L. O. Sillerud, Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging. Mol. Imaging 6, 277 (2007).
53. E. Ribot, A. K. Bouzier-Sore, V. Bouchaud, S. Miraux, M. H. Delville, J. M. Franconi, and P. Voisin, Microglia used as vehicles for both inducible thymidine kinase gene therapy and MRI contrast agents for glioma therapy. Cancer Gene Ther. 14, 724 (2007).
54. S. W. Zielhuis, J. H. Seppenwoolde, V. A. Mateus, C. J. Bakker, G. C. Krijger, G. Storm, B. A. Zonnenberg, A. D. van het Schip, G. A. Koning, and J. F. Nijsen, Lanthanide-loaded liposomes for multimodality imaging and therapy. Cancer Biother. Radiopharm. 21, 520 (2006).
55. M. Kumagai, Y. Imai, T. Nakamura, Y. Yamasaki, M. Sekino, S. Ueno, K. Hanaoka, K. Kikuchi, T. Nagano, E. Kaneko, K. Shimokado, and K. Kataoka, Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging. Colloids Surf. B. Biointerfaces 15, 174 (2007).
56. L. Du, J. Chen, Y. Qi, D. Li, C. Yuan, M. C. Lin, D. T. Yew, H. F. Kung, J. C. Yu, and L. Lai, Preparation and biomedical application of a non-polymer coated superparamagnetic nanoparticle. Int. J. Nanomedicine 2, 805 (2007).
57. H. L. Ma, Y. F. Xu, X. R. Qi, Y. Maitani, and T. Nagai, Super-paramagnetic iron oxide nanoparticles stabilized by alginate: Pharmacokinetics, tissue distribution, and applications in detecting liver cancers. Int. J. Pharm. 16, 217 (2008).
58. H. Lee, M. K. Yu, S. Park, S. Moon, J. J. Min, Y. Y. Jeong, H. W. Kang, and S. Jon, Thermally cross-linked superparamagnetic iron oxide nanoparticles: Synthesis and application as a dual imaging probe for cancer in vivo. J. Am. Chem. Soc. 24, 12739 (2007).
59. S. H. Choi, M. H. Han, W. K. Moon, K. R. Son, J. K. Won, J. H. Kim, B. J. Kwon, D. G. Na, H. J. Weinmann, and K. H. Chang, Cervical lymph node metastases: MR imaging of gadofluorine M and monocrystalline iron oxide nanoparticle-47 in a rabbit model of head and neck cancer. Radiology 241, 753 (2006).
60. X. Wu, J. Hu, L. Zhou, Y. Mao, B. Yang, L. Gao, R. Xie, F. Xu, D. Zhang, J. Liu, and J. Zhu, In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory Investigation. J. Neurosurg. 108, 320 (2008).
61. M. G. Harisinghani, J. Barentsz, P. F. Hahn, W. M. Deserno, S. Tabatabaei, C. H. van de Kaa, J. de la Rosette, and R. Weissleder, Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 19, 2491 (2003).
62. M. Johannsen, U. Gneveckow, B. Thiesen, K. Taymoorian, C. H. Cho, N. Waldöfner, R. Scholz, A. Jordan, S. A. Loening, and P. Wust, Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and three-dimensional temperature distribution. Eur. Urol. 52, 1653 (2007).
63. E. A. Neuwelt, C. G. Várallyay, S. Manninger, D. Solymosi, M. Haluska, M. A. Hunt, G. Nesbit, A. Stevens, M. Jerosch-Herold, P. M. Jacobs, and J. M. Hoffman, The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: A pilot study. Neurosurgery 60, 601 (2007).
64. S. J. Son and S. B. Lee, A platform for ultrasensitive and selective multiplexed marker protein assay toward early-stage cancer diagnosis. Nanomed. 2, 79 (2007).
65. 2 core-shell nanoparticle-based surface-enhanced Raman probes for immunoassay of cancer marker using silica-coated magnetic nanoparticles as separation tools. Biosens. Bioelectron. 15, 1501 (2007).
66. J. H. Lee, Y. M. Huh, Y. W. Jun, J. W. Seo, J. T. Jang, H. T. Song, S. Kim, E. J. Cho, H. G. Yoon, J. S. Suh, and J. Cheon, Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 13, 95 (2007).
67. H. Jin and K. A. Kang, Application of novel metal nanoparticles as optical/thermal agents in optical mammography and hyperthermic treatment for breast cancer. Adv. Exp. Med. Biol. 599, 45 (2007).
68. V. S. Kalambur, E. K. Longmire, and J. C. Bischof, Cellular level loading and heating of superparamagnetic iron oxide nanoparticles. Langmuir 20, 12329 (2007).
69. H. Jin, B. Hong, S. S. Kakar, and K. A. Kang, Tumor-specific nano-entities for optical detection and hyperthermic treatment of breast cancer. Adv. Exp. Med. Biol. 614, 275 (2008).
70. T. Kikumori, T. Kobayashi, M. Sawaki, and T. Imai, Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes. Breast Cancer Res. Treat. (2008).
71. N. Kawai, M. Futakuchi, T. Yoshida, A. Ito, S. Sato, T. Naiki, H. Honda, T. Shirai, and K. Kohri, Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone. Prostate 15, 784 (2008).
72. J. Motoyama, N. Yamashita, T. Morino, M. Tanaka, T. Kobayashi, and H. Honda, Hyperthermic treatment of DMBA-induced rat mammary cancer using magnetic nanoparticles. Biomagn. Res. Technol. 25, 2 (2008).
73. M. Johannsen, U. Gneveckow, K. Taymoorian, B. Thiesen, N. Waldöfner, R. Scholz, K. Jung, A. Jordan, P. Wust, and S. A. Loening, Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial. Int. J. Hyperthermia 23, 315 (2007).
74. 3 for magnetic hyperthermia. J. Biomed. Mater. Res. B. Appl. Biomater. 85, 409 (2008).
75. J. M. Wang, B. L. Xiao, J. W. Zheng, H. B. Chen, and S. Q. Zou, Effect of targeted magnetic nanoparticles containing 5-FU on expression of bcl-2, bax and caspase 3 in nude mice with transplanted human liver cancer. World J. Gastroenterol. 21, 3171 (2007).
76. T. Tang, J. W. Zheng, B. Chen, H. Li, X. Li, K. Y. Xue, X. Ai, and S. Q. Zou, Effects of targeting magnetic drug nanoparticles on human cholangiocarcinoma xenografts in nude mice. Hepatobiliary. Pancreat. Dis. Int. 6, 303 (2007).
77. M. Kettering, J. Winter, M. Zeisberger, C. Alexiou, S. Bremer-Streck, C. Bergemann, W. A. Kaiser, and I. Hilger, Magnetically based enhancement of nanoparticle uptake in tumor cells: Combination of magnetically induced cell labeling and magnetic heating. Rofo 178, 1255 (2006).
78. G. Hongwei, X. Keming, Y. Zhimou, K. Chi, X. Chang, and X. Bing, Synthesis and cellular uptake of porphyrin decorated iron oxide nanoparticles - A potential candidate for bimodal anticancer therapy. Chem. Commun. 14, 4270 (2005).
79. H. Gu, K. Xu, Z. Yang, C. K. Chang, and B. Xu, Synthesis and cellular uptake of porphyrin decorated iron oxide nanoparticles - A potential candidate for bimodal anticancer therapy. Chem. Commun. (Camb) 14, 4270 (2005).
80. P. K. Jain, X. Huang, I. H. El-Sayed, and M. A. El-Sayed, Noble metals on the nanoscale: Optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc. Chem. Res. 1 (2008).
81. C. Meng-Ya, S. Ai-Li, C. Yu-Hung, C. Chih-Jui, H. Helen, W. Chen, and W. Chao-Liang, Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice. Cancer Sci. 99, 1479 (2008).
82. M. E. Wieder, D. C. Hone, M. J. Cook, M. M. Handsley, J. Gavrilovic, and D. A. Russell, Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: Cancer therapy using a 'Trojan horse.' Photochem. Photobiol. Sci. 5, 727 (2006).
83. P. Podsiadlo, V. A. Sinani, J. H. Bahng, N. W. Kam, J. Lee, and N. A. Kotov, Gold nanoparticles enhance the anti-leukemia action of a 6-mercaptopurine chemotherapeutic agent. Langmuir 15, 568 (2008).
84. C. R. Patra, R. Bhattacharya, E. Wang, A. Katarya, J. S. Lau, S. Dutta, M. Muders, S. Wang, S. A. Buhrow, S. L. Safgren, M. J. Yaszemski, J. M. Reid, M. M. Ames, P. Mukherjee, and D. Mukhopadhyay, Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res. 15, 1970 (2008).
85. H. B. Yildiz, R. Freeman, R. Gill, and I. Willner, Electrochemical, photoelectrochemical, and piezoelectric analysis of tyrosinase activity by functionalized nanoparticles. Anal Chem. 15, 2811 (2008).
86. X. Liu, Q. Dai, L. Austin, J. Coutts, G. Knowles, J. Zou, H. Chen, and Q. Huo, A one-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. J. Am. Chem. Soc. 5, 2780 (2008).
87. C. D. Medley, J. E. Smith, Z. Tang, Y. Wu, S. Bamrungsap, and W. Tan, Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. Anal. Chem. 15, 1067 (2008).
88. Y. H. Chen, C. Y. Tsai, P. Y. Huang, M. Y. Chang, P. C. Cheng, C. H. Chou, D. H. Chen, C. R. Wang, A. L. Shiau, and C. L. Wu, Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol. Pharm. 4, 713 (2007).
89. J. M. Stern and J. A. Cadeddu, Emerging use of nanoparticles for the therapeutic ablation of urologic malignancies. Urol. Oncol. 26, 93 (2008).
90. J. M. Stern, J. Stanfield, W. Kabbani, J. T. Hsieh, and J. A. Cadeddu, Selective prostate cancer thermal ablation with laser activated gold nanoshells. J. Urol. 179, 748 (2008).
91. N. Nitin, D. J. Javier, and R. Richards-Kortum, Oligonucleotide-coated metallic nanoparticles as a flexible platform for molecular imaging agents. Bioconjug. Chem. 18, 2090 (2007).
92. J. Z. Zhang, A. M. Schwartzberg, T. J. Norman, Jr., C. D. Grant, J. Liu, F. Bridges, and T. van Buuren, Comment on 'gold nanoshells improve single nanparticle molecular sensors. Nano Lett. 5, 809 (2005).
93. 2S/Au core/shell particles. J. Phys. Chem. C 111, 8892 (2007).
94. A. M. Schwartzberg, T. Y. Olson, C. Talley, and J. Z. Zhang, Synthesis, characterization and tunable optical properties of hollow gold nanospheres. J. Phys. Chem. B 110, 19935 (2006).
95. B. D. Chithrani, A. A. Ghazani, and W. C. W. Chan, Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6, 662 (2006).
96. M. P. Melancon, W. Lu, Z. Yang, R. Zhang, Z. Cheng, A. M. Elliot, J. Stafford, T. Olson, J. Z. Zhang, and C. Li, In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptors for photothermal ablation therapy. Mole. Cancer Thera. 7, 1730 (2008).
97. W. Lu, C. Xiong, C. G. Zhang, Q. Huang, R. Zhang, J. Z. Zhang, and C. Li, Targeted photothermal ablation with hollow gold nanospheres in tumor-bearing mice. Cancer Res. (2008), submitted.
98. W. Chen, J. Z. Zhang, and A. G. Joly, Optical properties and potential applications of doped semiconductor nanoparticles. J. Nanosci. Nanotechnol. 4, 919 (2004).
99. W. Chen and J. Zhang, Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J. Nanosci. Nanotechnol. 6, 1159 (2006).
100. W. Chen, Nanoparticle fluorescence based technology for biological applications. J. Nanosci. Nanotechnol. 8, 1019 (2008).